These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4992294)

  • 1. [Study of attenuated strain of myxoma virus].
    Maral R
    C R Acad Hebd Seances Acad Sci D; 1970 Aug; 271(8):737-9. PubMed ID: 4992294
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myxomatosis of rabbits--study of virus modification].
    Jiran E; Sladká M; Kunstýr I
    Zentralbl Veterinarmed B; 1970 Mar; 17(3):418-28. PubMed ID: 5516854
    [No Abstract]   [Full Text] [Related]  

  • 3. Myxomatosis: the virulence of field strains of myxoma virus in a population of wild rabbits (Oryctolagus cuniculus L.) with high resistance to myxomatosis.
    Edmonds JW; Nolan IF; Shepherd RC; Gocs A
    J Hyg (Lond); 1975 Jun; 74(3):417-8. PubMed ID: 1056963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis.
    Kerr PJ; Perkins HD; Inglis B; Stagg R; McLaughlin E; Collins SV; Van Leeuwen BH
    Virology; 2004 Jun; 324(1):117-28. PubMed ID: 15183059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On a strain of Sanarelli virus attenuated by passage through cell cultures].
    Jacotot H; Virat B; Reculard P; Vallée A
    Bull Acad Vet Fr; 1967 May; 40(5):255-60. PubMed ID: 5595260
    [No Abstract]   [Full Text] [Related]  

  • 6. The development of genetic resistance to myxomatosis in wild rabbits in Britain.
    Ross J; Sanders MF
    J Hyg (Lond); 1984 Jun; 92(3):255-61. PubMed ID: 6736637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.
    Mossman K; Nation P; Macen J; Garbutt M; Lucas A; McFadden G
    Virology; 1996 Jan; 215(1):17-30. PubMed ID: 8553583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myxoma virus in rabbits.
    Kerr PJ; Best SM
    Rev Sci Tech; 1998 Apr; 17(1):256-68. PubMed ID: 9638815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of two vaccination schemes against experimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain.
    Marlier D; Mainil J; Boucraut-Baralon C; Linden A; Vindevogel H
    J Comp Pathol; 2000; 122(2-3):115-22. PubMed ID: 10684680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the virulence of myxoma virus strains in Britain.
    Ross J; Sanders MF
    Epidemiol Infect; 1987 Feb; 98(1):113-7. PubMed ID: 3556434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.
    Cavadini P; Botti G; Barbieri I; Lavazza A; Capucci L
    Vaccine; 2010 Jul; 28(33):5414-20. PubMed ID: 20598407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of rabbit myxomatosis in Poland.
    Górski J; Mizak B; Chrobocińska M
    Rev Sci Tech; 1994 Sep; 13(3):869-79. PubMed ID: 7949359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental infection of specific pathogen-free New Zealand White rabbits with five strains of amyxomatous myxoma virus.
    Marlier D; Cassart D; Boucraut-Baralon C; Coignoul F; Vindevogel H
    J Comp Pathol; 1999 Nov; 121(4):369-84. PubMed ID: 10542126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression.
    Boutard B; Vankerckhove S; Markine-Goriaynoff N; Sarlet M; Desmecht D; McFadden G; Vanderplasschen A; Gillet L
    PLoS One; 2015; 10(2):e0118806. PubMed ID: 25705900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination strategies against myxomavirus infections: are we really doing the best?
    Marlier D
    Tijdschr Diergeneeskd; 2010 Mar; 135(5):194-8. PubMed ID: 20334023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus.
    Messud-Petit F; Gelfi J; Delverdier M; Amardeilh MF; Py R; Sutter G; Bertagnoli S
    J Virol; 1998 Oct; 72(10):7830-9. PubMed ID: 9733819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits.
    Best SM; Kerr PJ
    Virology; 2000 Feb; 267(1):36-48. PubMed ID: 10648181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation.
    Zúñiga MC
    Virus Res; 2002 Sep; 88(1-2):17-33. PubMed ID: 12297325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the existence of latent myxoma virus in rabbits (Oryctolaqus cuniculus(L.)).
    Williams RT; Dunsmore JD; Parer I
    Nature; 1972 Jul; 238(5359):99-101. PubMed ID: 4557791
    [No Abstract]   [Full Text] [Related]  

  • 20. Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins.
    Guerin JL; Gelfi J; Boullier S; Delverdier M; Bellanger FA; Bertagnoli S; Drexler I; Sutter G; Messud-Petit F
    J Virol; 2002 Mar; 76(6):2912-23. PubMed ID: 11861858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.